177 related articles for article (PubMed ID: 19618)
1. Participation of an endogenous Ca++-blinding protein activator in the development of drug-induced supersensitivity of striatal dopamine receptors.
Gnegy M; Uzunov P; Costa E
J Pharmacol Exp Ther; 1977 Sep; 202(3):558-64. PubMed ID: 19618
[No Abstract] [Full Text] [Related]
2. Blockade of lergotrile or apomorphine induced turning behavior by haloperidol and clozapine.
Nakamura S; Engel J; Goldstein M
Commun Psychopharmacol; 1978; 2(3):185-90. PubMed ID: 29742
[No Abstract] [Full Text] [Related]
3. The effect of amantadine HCl on haloperidol-induced striatal dopamine neuron hypersensitivity.
Allen RM; Flemenbaum A
Biol Psychiatry; 1979 Jun; 14(3):541-4. PubMed ID: 573144
[No Abstract] [Full Text] [Related]
4. Reversal of two manifestations of dopamine receptor supersensitivity by administration of L-dopa.
Friedhoff AJ; Bonnet K; Tosengarten H
Res Commun Chem Pathol Pharmacol; 1977 Mar; 16(3):411-23. PubMed ID: 847296
[TBL] [Abstract][Full Text] [Related]
5. Dopamine-sensitive adenylate cyclase and dopamine/neuroleptic receptor binding: effect of neuroleptic drugs.
Marshall AM; Mishra RK
Adv Biochem Psychopharmacol; 1980; 24():153-7. PubMed ID: 6105772
[No Abstract] [Full Text] [Related]
6. Drug effects on pre- and postsynaptic dopamine receptors.
Andén NE; Grabowska-Andén M
Adv Biochem Psychopharmacol; 1980; 24():57-64. PubMed ID: 6105802
[No Abstract] [Full Text] [Related]
7. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
Rupniak NM; Kilpatrick G; Hall MD; Jenner P; Marsden CD
Psychopharmacology (Berl); 1984; 84(4):512-9. PubMed ID: 6441952
[TBL] [Abstract][Full Text] [Related]
8. Dopamine receptor mechanisms: behavioral and electrophysiological studies.
Ungerstedt U; Ljungberg T; Schultz W
Adv Biochem Psychopharmacol; 1978; 19():311-21. PubMed ID: 29451
[No Abstract] [Full Text] [Related]
9. Dopaminergic receptor activity in substantia nigra in the mechanisms of autoregulation of striatal dopamine release.
Groppetti A; Parenti M; Cattabeni F; Maggi A; De Angelis L; Monduzzi M; Racagni G
Adv Biochem Psychopharmacol; 1978; 19():363-71. PubMed ID: 696464
[No Abstract] [Full Text] [Related]
10. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.
Rupniak NM; Hall MD; Mann S; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
Biochem Pharmacol; 1985 Aug; 34(15):2755-63. PubMed ID: 4040370
[TBL] [Abstract][Full Text] [Related]
11. Role of calmodulin-dependent phosphorylation in chronic sulpiride-induced striatal dopamine receptor supersensitivity.
Lau YS; Runice C; Dowd F
J Pharmacol Exp Ther; 1984 Apr; 229(1):32-7. PubMed ID: 6323689
[TBL] [Abstract][Full Text] [Related]
12. Role of opiates in striatal D-1 dopamine receptor supersensitivity induced by chronic L-dopa treatment.
Groppetti A; Ceresoli G; Mandelli V; Parenti M
J Pharmacol Exp Ther; 1990 Jun; 253(3):950-6. PubMed ID: 2162953
[TBL] [Abstract][Full Text] [Related]
13. Long-term adaptive changes in striatal dopamine function in response to chronic neuroleptic intake in rats.
Jenner P; Kerwin R; Rupniak NM; Murugaiah K; Hall MD; Fleminger S; Marsden CD
J Neural Transm Suppl; 1983; 18():205-12. PubMed ID: 6135741
[TBL] [Abstract][Full Text] [Related]
14. Chronic sulpiride treatment produces supersensitivity of striatal adenylate cyclase to dopamine in sexually immature or adult castrated rats.
Gnegy ME; Bernabei A; Treisman G
J Pharmacol Exp Ther; 1983 Mar; 224(3):627-33. PubMed ID: 6827485
[TBL] [Abstract][Full Text] [Related]
15. Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia.
Gordon JH; Diamond BI
Biol Psychiatry; 1981 Apr; 16(4):365-71. PubMed ID: 7194695
[TBL] [Abstract][Full Text] [Related]
16. In vivo actions of clozapine and haloperidol on the turnover rate of acetylcholine in rat striatum.
Racagni G; Cheney DL; Trabucchi M; Costa E
J Pharmacol Exp Ther; 1976 Feb; 196(2):323-32. PubMed ID: 943521
[TBL] [Abstract][Full Text] [Related]
17. Aging and the regulation of striatal dopaminergic mechanisms in mice.
Randall PK; Severson JA; Finch CE
J Pharmacol Exp Ther; 1981 Dec; 219(3):695-700. PubMed ID: 7197719
[TBL] [Abstract][Full Text] [Related]
18. Presynaptic dopamine receptors in striatal nerve endings: absence of haloperidol-induced supersensitivity.
Raiteri M; Cerrito F; Casazza G; Levi G
Adv Biochem Psychopharmacol; 1980; 24():37-43. PubMed ID: 7405669
[No Abstract] [Full Text] [Related]
19. Differential alteration of striatal D-1 and D-2 receptors induced by the long-term administration of haloperidol, sulpiride or clozapine to rats.
Jenner P; Rupniak NM; Marsden CD
Psychopharmacology Suppl; 1985; 2():174-81. PubMed ID: 3159009
[TBL] [Abstract][Full Text] [Related]
20. The pathophysiology of tardive dyskinesia.
Klawans HL; Carvey P; Tanner CM; Goetz CG
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):38-41. PubMed ID: 2858479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
